valsartan/amlodipine
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Primary Hypertension
Conditions
Primary Hypertension
Trial Timeline
Feb 1, 2009 → Jan 1, 2011
NCT ID
NCT01241487About valsartan/amlodipine
valsartan/amlodipine is a approved stage product being developed by Novartis for Primary Hypertension. The current trial status is completed. This product is registered under clinical trial identifier NCT01241487. Target conditions include Primary Hypertension.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01241487 | Approved | Completed |
| NCT00171002 | Phase 3 | Completed |
| NCT00171535 | Phase 3 | Completed |
| NCT00170963 | Phase 3 | Completed |
Competing Products
20 competing products in Primary Hypertension